Dr. Pinder-Schenck is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
572 Marlin Ct
Redwood City, CA 94065Phone+1 267-251-1601
Education & Training
- University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 2005 - 2008
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2005 - 2007
- University of North Carolina HospitalsResidency, Internal Medicine, 2002 - 2005
- Stanford University School of MedicineClass of 2002
Certifications & Licensure
- CA State Medical License 2024 - 2026
- PA State Medical License 2016 - 2016
- FL State Medical License 2009 - 2015
Clinical Trials
Publications & Presentations
PubMed
- 433 citationsCongestive Heart Failure in Older Women Treated With Adjuvant Anthracycline Chemotherapy for Breast CancerMary Colleen Pinder, Zhigang Duan, James S. Goodwin, Gabriel N. Hortobagyi, Sharon H. Giordano
Journal of Clinical Oncology. 2007-09-01 - 904 citationsOverall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell...Scott N. Gettinger, Leora Horn, Leena Gandhi, David R. Spigel, Scott J. Antonia
Journal of Clinical Oncology. 2015-04-20 - 311 citationsNon-small cell lung cancer, version 2.2013: Featured updates to the NCCN guidelinesDavid S. Ettinger, Wallace Akerley, Hossein Borghaei, Andrew C. Chang, Richard T. Cheney
Journal of the National Comprehensive Cancer Network. 2013-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: